By American College of Cardiology
This app is only available on the App Store for iOS devices.
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
What's New in Version 2.3
• Updated stroke risk values on no therapy in accordance with ACC/AHA Guidelines.
• Additional reference information on risk calculations.
- Category: Medical
- Updated: May 22, 2017
- Version: 2.3
- Size: 12.8 MB
- Language: English
- Seller: American College of Cardiology
- © 2015 American College of Cardiology
Compatibility: Requires iOS 8.0 or later. Compatible with iPhone, iPad, and iPod touch.